Clinical Trial Update: Endothelial Dysfunction Evaluation for Coronary Heart Disease Risk Estimation in Rheumatoid Arthritis (EDRA Study)

View source ↗

Summary

Clinical trial update on the EDRA study evaluating endothelial dysfunction to estimate coronary heart disease risk in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Rheumatoid Arthritis

Snippet

Sponsor: Azienda Ospedaliero Universitaria di Sassari | Conditions: Rheumatoid Arthritis, Coronary Heart Disease | Status: UNKNOWN